A Randomised, Controlled Study of the Effects of Aerobic Exercise and Dietary Fish on Coagulation and Fibrinolytic Factors in Type 2 Diabetics
David W. Dunstan
1
From the Departments of Medicine and Human Movement, University of Western Australia, West Australian Heart Research Institute, Department of Diabetes and Endocrinology, Royal Perth Hospital, Australia
,
Trevor A. Mori
1
From the Departments of Medicine and Human Movement, University of Western Australia, West Australian Heart Research Institute, Department of Diabetes and Endocrinology, Royal Perth Hospital, Australia
,
Ian B. Puddey
1
From the Departments of Medicine and Human Movement, University of Western Australia, West Australian Heart Research Institute, Department of Diabetes and Endocrinology, Royal Perth Hospital, Australia
,
Lawrie J. Beilin
1
From the Departments of Medicine and Human Movement, University of Western Australia, West Australian Heart Research Institute, Department of Diabetes and Endocrinology, Royal Perth Hospital, Australia
,
Valerie Burke
1
From the Departments of Medicine and Human Movement, University of Western Australia, West Australian Heart Research Institute, Department of Diabetes and Endocrinology, Royal Perth Hospital, Australia
,
Alan R. Morton
1
From the Departments of Medicine and Human Movement, University of Western Australia, West Australian Heart Research Institute, Department of Diabetes and Endocrinology, Royal Perth Hospital, Australia
,
Kim G. Stanton
1
From the Departments of Medicine and Human Movement, University of Western Australia, West Australian Heart Research Institute, Department of Diabetes and Endocrinology, Royal Perth Hospital, Australia
› InstitutsangabenThis study was financially supported by grants from the West Australian Health Promotion Foundation (Healthway), the Royal Perth Hospital Medical Research Foundation and a program grant from the National Health and Medical Research Council of Australia.
Type 2 diabetes is associated with disturbances in coagulation and fibrinolysis. Prospective studies show that increased tissue plasminogen activator (tPA) antigen increases the risk of cardiovascular mortality. The present study examined the hypothesis that combining a regime of moderate aerobic exercise with one daily fish meal as part of a low-fat diet (30% total energy) would improve coagulation and fibrinolytic factors in dyslipidaemic type 2 diabetic patients. In a randomised, controlled, 8-week trial, 55 sedentary type 2 diabetic subjects with serum triglycerides >1.8 mmol/l and/or HDL-C <1.0 mmol/l were randomly assigned to a low-fat diet (30% daily energy intake) with or without one fish meal daily (3.6 g ω3 fatty acids/day) and further randomized to a moderate (55-65% VO2max) or light (heart rate <100 bpm) exercise program. Plasma levels of fibrinogen, coagulation factor VIIc, tPA and plasminogen activator inhibitor (PAI-1) antigen were measured before and after intervention. In the 49 subjects who completed the study, the fish diet alone, moderate exercise alone and the combination of fish and moderate exercise all led to significant reductions in tPA antigen concentrations (-2.1 ng/ml, p = 0.02, -1.9 ng/ml, p = 0.03, -2.0 ng/ml, p = 0.01, respectively) compared to controls. In multivariate regression, changes in fasting blood glucose (positively) and erythrocyte ω3 fatty acid composition (inversely) were independent predictors of the change in tPA antigen. The fish diet alone contributed to a significant rise in coagulation factor VIIc compared to controls (4.9%, p = 0.02), which was prevented by moderate exercise. No significant effects on PAI-1 antigen and fibrinogen were seen. In view of recent epidemiological findings, the reduction in tPA antigen with both fish and moderate exercise in these dyslipidaemic type 2 diabetic patients could reflect a reduced thrombotic potential and decreased cardiovascular risk. Furthermore, a small, albeit significant, increase in coagulation factor VIIc associated with fish can be prevented by a concomitant programme of moderate exercise.
References
1
Pyorala K,
Laasko M,
Uusitupa M.
Diabetes and atherosclerosis. Diabetes Metab Rev 1987; 3: 463-524.
2
De Wood M,
Spores J,
Notske R,
Mouser LT,
Burroughs R,
Golden MS,
Lange HT.
Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. New Engl J Med 1980; 303: 897-902.
4
Heinrich J,
Balleisen L,
Schulte H,
Assman G,
van de Loo J.
Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-9.
5
Meade TW,
Ruddock V,
Stirling Y,
Chakrabarti R,
Miller GJ.
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-9.
6
Jansson J,
Olofsson B,
Nilsson TK.
Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation 1993; 88: 2030-4.
7
Ridker PM,
Vaughan DE,
Stampfer MJ,
Manson JE,
Hennekens CH.
Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165-8.
8
Ridker PM,
Hennekens CH,
Stampfer MJ,
Manson JE,
Vaughan DE.
Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994; 343: 940-3.
9
Thompson SG,
Kienast J,
Pyke SDM,
Haverkate F,
van de Loo JCW.
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl J Med 1995; 332: 635-41.
10
Brannstrom M,
Jansson J,
Boman K,
Nilsson TK.
Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment. Thromb Haemost 1995; 74: 612-5.
11
Hamsten A,
Walldius G,
Szamosi A,
Blombäck M,
De Faire U,
Dahlen G,
Landou C,
Wiman B.
Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet 1987; II: 3-9.
13
Morishita E,
Asakura H,
Jokaji H,
Saito M,
Uotani C,
Kumabashiri I,
Yamazaki M,
Aoshima K,
Hashimoto T,
Matsuda T.
Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. Atherosclerosis 1996; 120: 7-14.
14
Juhan-Vague I,
Alessi MC,
Vague P.
Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457-62.
16
Hiraga T,
Shimada M,
Tsukada T,
Murase T.
Hypertriglyceridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system. Horm Metab Res 1996; 28: 603-6.
17
Dunstan DW,
Mori TA,
Puddey IB,
Beilin LJ,
Burke V,
Morton AR,
Stanton KG.
The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomised controlled study. Diabetes Care 1997; 20: 913-21.
20
Mori TA,
Vandongen R,
Beilin LJ,
Burke V,
Morris J,
Ritchie J.
Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Clin Nutr 1994; 59: 1060-8.
21
Chandler WL,
Trimble SL,
Loo WC,
Mornin D.
Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma. Blood 1990; 76: 930-7.
22
Nilsson TK.
Analysis of factors affecting tissue plasminogen activator activity and antigen concentration before and after venous occlusion in 123 patients. Clin Chem Enzymol Commun 1989; 1: 335-41.
23
Eliasson M,
Evrin PE,
Lundblad D,
Asplund K,
Ranby M.
Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen. A population study. Fibrinolysis 1993; 7: 316-23.
27
Schneider SH,
Kim HC,
Khachadurian AK,
Ruderman NB.
Impaired fibrinolytic response to exercise in Type 2 diabetes: Effects of exercise and physical training. Metabolism 1988; 37: 924-9.
28
Williams RS,
Logue EE,
Lewis JL,
Barton T,
Stead NW,
Wallace AG,
Pizzo SV.
Physical conditioning augments the fibrinolytic response to venous occlusion in healthy adults. New Engl J Med 1980; 302: 987-91.
29
Stratton JR,
Chandler WL,
Schwartz RS,
Cerqueira MD,
Levy WC,
Kahn SE,
Larson VG,
Cain KC,
Beard JC,
Abrass IB.
Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old adults. Circulation 1991; 83: 1692-7.
30
De Geus EJC,
Kluft C,
De Bart ACW,
Van Doornen LJP.
Effects of exercise training on plasminogen activator inhibitor activity. Med Sci Sports Exerc 1992; 24: 1210-9.
32
Anderssen SA,
Haaland A,
Hjermann I,
Urdal P,
Gjesdal K,
Holme I.
Oslo diet and exercise study: a one-year randomized intervention trial. Effect on hemostatic variables and other coronary risk factors. Nutr Metab Cardiovasc Dis 1995; 5: 189-200.
33
Pandolfi A,
Iacoviello L,
Capani F,
Vitacolonna E,
Donati MB,
Consoli A.
Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. Diabetologia 1996; 39: 1425-31.
34
Nordt TK,
Klassen KJ,
Schneider DJ,
Sobel BE.
Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial cells by glucose and its implications for local fibrinolysis. Arterioscler Thromb 1993; 13: 1822-8.
36
Hellsten G,
Boman K,
Saarem K,
Hallmans G.
Effects on fibrinolytic activity of corn oil and a fish oil preparation enriched with omega-3-polyunsaturated fatty acids in a long-term study. Curr Med Res Opin 1993; 13: 133-9.
37
Toft I,
Bonaa KH,
Ingebretsen OC,
Nordoy A,
Jenssen T.
Fibrinolytic function after dietary supplementation with ω3 fatty acids. Arterioscler Thromb Vasc Biol 1997; 17: 814-9.
38
Emeis JJ,
van Houwelingen AC,
van den Hoogen CM,
Hornstra G.
A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood 1989; 74: 233-237.
40
Eritsland J,
Seljeflot I,
Abdelnoor M,
Arnesen H.
Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids. Fibrinolysis 1994; 8: 120-5.
41
Oosthuizen W,
Vorster HH,
Jerling JC,
Barnard HC,
Smuts CM,
Silvis N,
Kruger A,
Venter CS.
Both fish oil and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels. Thromb Haemost 1994; 72: 557-62.
44
Boberg M,
Pollare T,
Siegbahn A,
Vessby B.
Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1992; 22: 645-50.
45
Ceriello A,
Giugliano D,
Quatraro A,
Dello Russo P,
Torella R.
Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988; 31: 889-91.
46
Westerveld HT,
De Graaf JC,
van Breugel I HHF,
Akkerman JWN,
Sixma JJ,
Erkelens DW,
Banga JD.
Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM. Diabetes Care 1993; 16: 683-7.
47
Haines AP,
Sanders TAB,
Imeson JD,
Mahler RF,
Martin J,
Mistry M,
Vickers M,
Wallace PG.
Effects of a fish oil supplement on platelet function, hemostatic variables and albuminuria in insulin-dependent diabetics. Thromb Res 1986; 43: 643-55.
48
Radack K,
Deck C,
Huster G.
Dietary supplementation with low-dose fish oils lowers fibrinogen levels: A randomized, double-blind controlled study. Ann Intern Med 1989; 111: 757-8.
49
Hwang DH,
Chanmugam PS,
Ryan DH,
Boudreau MD,
Windhauser MM,
Tulley RT,
Brooks ER,
Bray GA.
Does vegetable oil attenuate the beneficial effects of fish oil in reducing risk factors for cardiovascular disease?. Am J Clin Nutr 1997; 66: 89-96.
50
Wosornu D,
Allardyce W,
Tansey P.
Influence of power and aerobic exercise training on haemostatic factors after coronary artery surgery. Br Heart J 1992; 68: 181-6.
51
Schuit AJ,
Schouten EG,
Kluft C,
de Maat M,
Menheere PPCA,
Kok FJ.
Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women. Thromb Haemost 1997; 78: 845-51.
52
Mori TA,
Beilin LJ,
Burke V,
Morris J,
Ritchie J.
Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997; 17: 279-86.
